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Abstract
Introduction In mechanically ventilated patients, sedation
strategies are a major determinant of outcome. The
emergency department (ED) is the earliest exposure to
mechanical ventilation for hundreds of thousands of patients
annually in the USA. The one retrospective study that exists
regarding ED sedation for mechanically ventilated patients
showed a strong association between deep sedation in the
ED and worse clinical outcomes. This finding suggests that
the ED may be an optimal location to study the impact of
early sedation on outcome, yet a lack of prospective studies
represents a knowledge gap in this arena. This protocol
describes a prospective observational study aimed at further
characterising ED sedation practices and assessing the
relationship between ED sedation and clinical outcomes.
An association between ED sedation and clinical outcomes
across multiple sites would suggest the need for changes in
the current sedation strategies used in the ED, and provide
evidence for future interventional studies in this field.
Methods and analysis This is a multicentre, prospective
cohort study testing the hypothesis that deep sedation in the
ED is associated with worse clinical outcomes. A cohort of
over 300 mechanically ventilated ED patients will be included.
The primary outcome is ventilator-free days, and secondary
outcomes include hospital mortality, incidence of acute
brain dysfunction and lengths of stay. Multivariable linear
regression will test the hypothesis that deep sedation in the
ED is associated with a decrease in ventilator-free days.
Ethics and dissemination Approval of the study by the
Institutional Review Board (IRB) at each participating site has
been obtained prior to data collection on the first patient. This
work will be disseminated by publication of peer-reviewed
manuscripts, presentation in abstract form at scientific
meetings and data sharing with other investigators through
academically established means.

Introduction
Background and rationale
Provision of analgesia and sedation is ubiquitous in the care of mechanically ventilated

Strengths and limitations of this study
►► This study is the first to examine prospectively the

impact of emergency department (ED) sedation on
clinical outcomes.
►► The observational design will allow the enrolment
of a large sample of diverse patients, which will add
significantly to the knowledge base regarding current ED sedation practices.
►► The multicentre nature of the study will increase external validity of the findings.
►► An observational design can only describe associations and not causation.
►► The study will rely on real-world assessments and
documentation of sedation depth and the presence
of delirium, which could be prone to inaccuracies.

patients. While sedation was historically
viewed as a means to adapt the patient to the
ventilator and facilitate care, recent studies
demonstrate that sedation strategies (eg,
depth of sedation and medications delivered)
are highly influential on clinical outcomes
in mechanically ventilated patients.1 2 Given
this, guidelines for intensive care unit (ICU)
sedation recommend: (1) maintaining light
levels of sedation unless clinically contraindicated; (2) objectively monitoring depth of
sedation; (3) using non-benzodiazepine sedation strategies and (4) routinely monitoring
for the presence of delirium.1
The majority of data in this domain comes
from randomised controlled trials (RCTs)
which enrolled patients after 48–96 hours
of mechanical ventilation, or observational
data centred on an entire ICU stay.3 The
early period of mechanical ventilation (ie,
in the emergency department (ED) and first
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the paradigm of early deep sedation, these immunomodulatory effects can be seen early, within 1–2 hours.18
The data regarding ED sedation only exist from our
centre. It is unknown if our results are generalisable to
other EDs, and this represents a significant knowledge
gap. Therefore, prior to the planning of any potential
interventional studies, we feel it important to further
investigate the current state of ED sedation in critically
ill mechanically ventilated patients. Given the clinical
outcome data associated with early sedation, as well as the
preliminary ED-based data from our centre, we designed
this study with the objectives to: (1) further characterise
modern ED sedation practices across multiple sites and
(2) assess the relationship between ED sedation and clinical outcomes.
Specific aims
Aim 1
To assess the relationship between ED sedation (depth
and agents used) and clinical outcomes. We hypothesise
that deep sedation in the ED will be independently associated with significant differences in clinical outcomes after
admission to the ICU.
Aim 2
To characterise ED sedation practices for mechanically
ventilated patients across a diverse cohort of academic
institutions.
Significance
It is likely that sedation in mechanically ventilated patients
is highly influential on patient-centred outcomes, such
as ventilator-free days, mortality, delirium incidence and
lengths of stay. Accurate assessment of ED sedation and
improved understanding of outcomes associated with ED
sedation can help guide decision making, improve patient
care and assist in the planning of future clinical studies. It
appears to be common for patients to be deeply sedated
in the ED, which is discordant with ICU-based guideline
recommendations.1 7 However, it is possible that sedation
requirements and approaches may be distinctly different
in the ED from those in the ICU, and existing guidelines
may not be applicable. Our initial data show that ED-based
sedation could be highly influential on outcome. Going
forward, a strong association between ED sedation and
clinical outcomes across multiple sites would suggest the
need for changes in the current standard of care in the
ED, and provide evidential need for intervention studies
in this area.

Methods and analysis
Study design
This is a multicentre, prospective cohort study. Using
a cross-sectional approach, data for each centre will be
collected during a 1-month time period between 1 June
and 31 August 2018. A schematic of the design appears
in figure 1.
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48 hours in ICU) has been largely ignored, yet may be
particularly influential on outcome.4 In the most comprehensive evaluation of the world’s literature to date, our
group previously showed a strong association between
early (within 48 hours of instituting mechanical ventilation) sedation depth and outcome.3 Early light sedation
was associated with lower hospital mortality (9.2%) versus
deep sedation (27.6%) (OR 0.34, 95% CI 0.21 to 0.54),
p<0.001. The frequency of delirium was 28.7% in lightly
sedated patients versus 48.4% in the deep sedation group
(p=0.11). Early light sedation was also associated with
fewer mechanical ventilator days (mean difference, −2.1
(95% CI −3.6 to −0.5), p=0.008) and shorter ICU lengths
of stay (mean difference, −3.0 days (95% CI −5.4 to −0.6)),
p=0.02.3 This systematic review and meta-analysis also
identified a critical knowledge gap regarding early sedation and its potential impact on outcome, as the majority
of data was from retrospective cohort studies, and only
two pilot RCTs (n=97 patients) have been conducted.5 6
The ED is the most proximal time period of mechanical
ventilation for many critically ill patients, yet little attention has been given to the impact that ED-based sedation
may have on outcome. Our preliminary data suggest that
the ED may be an optimal location to study the impact
of early sedation for several reasons.7 First, deep sedation
in the ED is common (64%), with a median Richmond
Agitation-Sedation Scale (RASS) of −3.0 (−4.0 to −2.0).
Evidence shows that this early oversedation can extend for
days in the ICU (sedation overshoot).8 This fact, paired
with our data, suggests that an ED-based goal-oriented
sedation intervention could not only reduce the negative
effects of deep sedation in the ED, but reduce sedation
overshoot early in the ICU as well. Second, deep sedation
in the ED is associated with higher mortality, and more
ventilator and ICU days.7 Third, approximately two-thirds
of mechanically ventilated ED patients receive benzodiazepines, a strategy shown to increase the incidence of
delirium, as well as the duration of mechanical ventilation and ICU length of stay. Targeting early sedation in
the ED seems needed, and may be an effective strategy to
reduce complications in this vulnerable cohort. This has
not been a topic of previous research.
In addition to the clinical outcome data mentioned
above, there is strong biological rationale for the avoidance of deep sedation by targeting the ED. Not only does
sedation exert profound effects on the brain, preclinical
data demonstrate that sedation has negative pleiotropic
effects on other organ systems. In the gastrointestinal
tract, sedatives and opiates can imbalance the microbiome, compromise intestinal barrier function, induce
bacterial translocation and increasing microbial virulence.9 In the microcirculation, deep sedation induces
deterioration in vasomotor function and response to
ischaemia, suggesting sedation strategy could affect
tissue perfusion at the microcirculatory level.10 In the
immune system, sedatives can inhibit neutrophil and
macrophage function, decrease bacterial clearance and
increase mortality in infected animals.11–17 Significant to
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Schematic of study design. ED, emergency department; ICU, intensive care unit.

Study population
The target population for this study is mechanically ventilated patients in the ED. Inclusion criteria are: (1) receipt
of invasive mechanical ventilation in the ED. Exclusion
criteria are: (1) death or discontinuation of mechanical
ventilation within 24 hours of presentation; (2) transfer
to another hospital from the ED; (3) presence of neurological injury as the indication for mechanical ventilation (eg, acute cerebrovascular accident, traumatic brain
injury, status epilepticus or sudden cardiac arrest) and
(4) chronic/home mechanical ventilation. Presence of
neurological injury is an exclusion criterion as patients
with neurological injury can have depressed levels of
consciousness that is independent of sedation, and therefore serve as a confounder between sedation depth and
clinical outcomes. Patients on chronic/home ventilation
may require vastly different sedation approaches (ie, no
sedation at all), given their chronic condition. Also, the
ability to calculate ventilator-free days in these patients
may not be possible.
Patients will be recruited exclusively from the ED, and
enrolled without regard to gender or race. Based on the
multicentre nature of this study, and the demographics
of the patient population routinely presenting to the ED,
we expect a diverse patient population. We, therefore,
expect that the study findings will hold external validity
and be applicable to the community as a whole.
Patient and public involvement
The patients in this study were not involved in the development of the research question or study design, and will
not be involved in recruitment or conduct of the study.
Data
We anticipate collecting the following baseline characteristics: age, gender, race, weight, height, pre-existing
comorbid conditions, vital signs at presentation and pertinent laboratory variables. Illness severity will be assessed
with the modified Sequential Organ Failure Assessment
(SOFA) score. This omits the Glasgow Coma Scale (GCS)
component of the SOFA score, which has poor interrater agreement; it is also collinear to measurements of
Fuller BM, et al. BMJ Open 2018;8:e023423. doi:10.1136/bmjopen-2018-023423

sedation depth.19–21 Comorbid conditions will include:
dementia, diabetes mellitus, cirrhosis, congestive heart
failure, end-stage renal disease, chronic obstructive
pulmonary disease, immunosuppression, malignancy,
alcohol abuse and history of psychiatric illness (eg, schizophrenia, bipolar, major depression or anxiety).
ED process of care variables will include: ED length
of stay, blood product transfusion, antibiotics, central
venous catheter placement and vasopressor infusion.
Data related to mechanical ventilation will include: location of intubation (ie, prehospital or ED), indication for
mechanical ventilation, ventilator mode, tidal volume,
positive end-expiratory pressure, set respiratory rate, fraction of inspired oxygen, peripheral oxygen saturation,
peak airway pressure and inspiratory plateau pressure.
Data related to sedation in the ED will include: neuromuscular blockers and induction agents administered to
facilitate endotracheal intubation. Subsequent medications related to analgesia and sedation in the ED will also
be collected, and will include: opiates, benzodiazepines,
propofol, ketamine, dexmedetomidine, etomidate, haloperidol, quetiapine and neuromuscular blocking agents.
Medications administered for the management of analgosedation during the first 48 hours of ICU admission will
also be collected. All antipsychotic agents, such as quetiapine and haloperidol, will be collected.
Sedation depth in the ED will be recorded. It is
recognised that multiple sedation scales exist for monitoring sedation depth in mechanically ventilated patients.
Given the observational and pragmatic design of the study,
sedation depth will be monitored according to the standard operating procedures already in place at an existing
site. This may include monitoring of sedation depth with
scales such as the (RASS; deep sedation defined as a score
of −3 to −5; preferential scale) or the Riker Sedation-Agitation Scale (deep sedation defined as a score of 2 or
1).22 If more than one sedation depth per patient is documented in the ED, then the median value will be used.7
As sedation in the ED for mechanically ventilated
patients has not been a research or clinical focus until
recently, it is also recognised that some EDs may not have
3
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protocols in place to routinely monitor sedation depth. In
this situation, we will use surrogates for depth of sedation,
which include a documented GCS (GCS <9 defined as
deep sedation).23 In patients for whom no sedation depth
is documented in the ED, the first ICU RASS will be used
as a surrogate for the ED depth of sedation, provided
that it is measured within the first 3 hours of ICU admission, congruent with our prior approach.7 Use of an early
ICU RASS score as a reliable surrogate for ED RASS is
supported by previous data demonstrating that sedation
depth remains relatively static during the first 24 hours of
ICU admission.4
Pertinent clinical data after admission, including the
first 48 hours of ICU sedation depth, will also be included.
Table 1 shows a full description of events for this study.
Outcomes
Patients will be followed until hospital discharge or
death. The primary outcome of interest is ventilator-free
days. Secondary outcomes include all cause in-hospital
mortality, the presence of acute brain dysfunction during
4

the first 48 hours in the ICU, as well as ICU-free and
hospital-free days.
Acute brain dysfunction is a composite outcome
composed of delirium and coma. Delirium will be
assessed by the Confusion Assessment Method for the
ICU (CAM-ICU) per local institutional protocols. This
is a highly reproducible and well-validated method for
diagnosing delirium in mechanically ventilated patients.
Coma will be defined as having all documented RASS (or
equivalent sedation scale) scores of −4 (responsive to only
physical stimulus) or −5 (unresponsive) during the first
48 hours. We elect to use this composite outcome since
both delirium and coma are major categories of cognitive dysfunction. As delirium cannot be assessed during
periods of coma, using this composite outcome provides a
more accurate event rate for the incidence of acute organ
dysfunction of the brain. This secondary outcome will be
assessed at 48 hours for two reasons: (1) early sedation
within this time frame has been strongly associated with
clinical outcome in the ICU4 24 25 and (2) initial sedation
approach often extends into this time period, providing a
temporal link to the sedation provided in the ED.7 8
Clinical outcomes will be assessed as a function of ED
sedation depth, with the a priori hypothesis being that
deep sedation will be associated with fewer ventilator-free
days, higher mortality, a greater incidence of acute brain
dysfunction and longer lengths of stay.
Descriptive outcomes include the sedative and analgesic medications administered in the ED. By assessing
this descriptive outcome, we will further characterise
ED-based sedation and assess potential targets for future
investigation. We will also describe early ICU sedation
practices during the first 48 hours after admission. If early
ICU sedation appears to be influenced by the initial sedation approach in the ED, this provides further rationale
that the ED should be the starting point and target for
future studies.
Proposed statistical methods
Patient characteristics will be assessed with descriptive
statistics and frequency distributions. Categorical characteristics will be compared using the χ2 test or Fisher’s
exact test. Continuous characteristics will be compared
using the independent samples t-test or Wilcoxon’s
rank-sum test.
The primary analysis will examine ventilator-free days
as a function of ED sedation depth. A multivariable linear
regression model will be constructed to adjust for potentially confounding variables using backward elimination.
A priori baseline characteristics with known prognostic
significance for mortality in ED mechanically ventilated
patients will be included in the model. Other clinically
relevant and biologically plausible variable that are statistically significant in univariate analysis at a p<0.10 level
will also be included in the model. Collinearity will be
assessed and the model will use variables that are statistically independent of other variables. All tests will be
two tailed, and a p<0.05 will be considered statistically
Fuller BM, et al. BMJ Open 2018;8:e023423. doi:10.1136/bmjopen-2018-023423
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Table 1 Schedule of events for this prospective cohort
study
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Sample size
We estimate our sample size calculation based on prior
work from the ICU which reported the impact of sedation on ventilator-free days,26–29 a cohort study regarding
early sedation depth and its impact on outcome,4 and
our single-centre cohort study examining the impact
of ED sedation depth on clinical outcome.7 We conservatively estimated a difference in mean (SD) ventilator-free days of 2.5 between the two groups: deep
sedation (18.5 (8.0)) vs light sedation (21.0 (8.0)). For
80% power and a α of 0.05, we will need a total sample
size 324 patients (162 per group). Based on our prior
work involving mechanically ventilated patients in the
ED, we expect approximately 0.75–1.0 patients to satisfy
inclusion and exclusion criteria per site, each day.30 31
With 16 centres agreeing to participate, we expect a total
sample size that is capable of achieving the objectives of
this investigation.
Anticipated results
We anticipate that deep sedation in the ED will be
common, as will the use of benzodiazepines for postintubation sedation. We also anticipate that the presence of
deep sedation in the ED will be associated with a reduction in ventilator-free days, higher mortality and a greater
incidence of acute brain dysfunction and longer lengths
of stay.
Data storage and management
All data will be entered by site principal investigators (PI)
or research assistants and data accuracy will be verified by
the study PI. Data quality control measures will include
queries to identify missing data, outliers and discrepancies. Only research assistants and site PIs will have access to
protected health information. After enrolment, a unique
identifier will be assigned to each study subject. The data
from all sites will be uploaded and stored using Research
Electronic Data Capture, a web-based data management
application. All computers will be password protected
and encrypted per university policy. The PI will ensure
that the anonymity is maintained. Patients will not be
identified by name in any reports on this study. The study
PI will have access to the final study dataset.
Fuller BM, et al. BMJ Open 2018;8:e023423. doi:10.1136/bmjopen-2018-023423

Ethics and dissemination
Dissemination and data sharing
To enhance reporting transparency, this study will be
reported in accordance with the Strengthening the
Reporting of Observational Studies in Epidemiology Statement: Guidelines for Reporting Observational Studies.32
Data and resources will be shared with other eligible
investigators through academically established means.
The datasets used and/or analysed during the study will
be available from the corresponding author on reasonable request. Collaboration with others investigators
interested in optimising outcomes for mechanically ventilated patients in the ED will be welcomed. The results
from this work will be published as a full-length, peer-reviewed manuscript and presented at national meetings.
Strengths and limitations
Strengths
Currently, only one retrospective cohort study has been
published regarding the impact of ED sedation on clinical outcome.7 The current investigation will add a significant amount of data to this research domain. Further, it
will address some of the prior weaknesses in this field: (1)
the multicentre nature of the study will enhance external
validity of the findings and (2) it will prospectively enrol
patients and capture data. This will allow us to track sedation depth as a potential function of illness severity or
neurological status with more accuracy, reducing potential confounders related to sedation depth.
Limitations
This study will have several limitations. As an observational
study, it will only be able to demonstrate associations and
not causation. We will attempt to enhance causal inference
in several ways. We will apply a rigorous multivariable analysis to address potential confounders. A scientific gap will be
addressed by enrolling across multiple sites and we will check
the consistency of our results with prior work in this field.
Finally, we will report all results transparently in accordance
with guideline recommendations, which have been shown
to improve reporting in observational studies.32 The observational cohort study design is also prone to confounders,
though this should be reduced somewhat by prospective
data collection. We also will have to rely on real-world assessments and documentation of sedation depth and the presence of delirium (CAM-ICU). While these assessments are
part of standard ED and ICU protocols for mechanically
ventilated patients, without dedicated study team members
performing these assessments, there is potential for inaccuracies. However, this does reflect daily practice and may
enhance external validity of our findings. The collection
of clinical data beyond 48 hours would be advantageous
for the association between ED sedation depth and other
clinical outcomes, such as organ failure and ICU-acquired
infections. Finally, the intent of this investigation is not to
produce definitive answers related to ED-based sedation
and its impact on outcome, but rather to provide further
exploratory data in this area and more preliminary data for
5
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significant. Time (in days) to mortality will be assessed
with the Kaplan-Meier survival estimate and log-rank test,
comparing the deep sedation and light sedation groups.
We will conduct a priori subgroup analyses to further
understand the treatment effect and identify subgroups
in which heterogeneous treatment effects exist. These
subgroups will be based on (but are not limited to):
illness severity, indication for mechanical ventilation
and specific medications received in the ED or ICU (eg,
benzodiazepines, dexmedetomidine). On study completion, additional analyses may be performed post hoc if
they are believed to contribute valuable or novel information, or if unforeseen imbalances in the data are present.
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